Tolerance, mixed chimerism and protection against graft-versus-host disease after total lymphoid irradiation

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 356, Issue 1409, 2001, Pages 739-748

  Field, E H ^a   Strober, S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chimerism; Graft versus host disease; Natural killer T cells; Tolerance; Total lymphoid irradiation

Indexed keywords

EID: 0035967462     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2001.0851     Document Type: Review

References (74)

1. - thymocytes with specific lymphokine secretion
2. - T-cell deficiency and IDDM in NOD/Lt mice
3. + T cells acquire specific lymphokine secretion potentials during thymic maturation
4. Activation events during thymic selection
5. Mouse CD1-specific NK1 T cells: Development, specificity, and function
6. Acquired tolerance of foreign cells in newborn animals
7. Prevention of graft-versus-host disease by ex vivo T cell depletion: Reduction in graft failure with augmented total body irradiation
8. Prevention of Th1 responses is critical for tolerance
9. Engraftment kinetics after non-myeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses
10. Hematologic neoplasia in patients treated for Hodgkin's disease
11. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers
12. Generation of polarized antigen-specific CD8 effector populations: Reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles
13. + TCR alpha beta in liver lymphocytes: Influence of thymus, beta 2-microglobulin and NK1.1 expression
14. The immuno-pathophysiology of acute graft-versus-host-disease
15. Alloantigen priming after total lymphoid irradiation alters alloimmune cytokine responses
16. Association between enhanced Th2/Th1 cytokine profile and donor T cell chimerism following total lymphoid irradiation
17. + lymphoid engraftment
18. + Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease
19. The role of interleukin 4 in the induction phase of allogeneic neonatal tolerance
20. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
21. +-like thymocytes in the NOD mouse
22. Allogeneic marrow transplantation after total lymphoid irradiation: Effect of dose/fraction, thymic irradiation, delayed marrow infusion, and presensitization
23. Engraftment of allogeneic bone marrow without graft versus host disease in mongrel dogs using total lymphoid irradiation
24. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10
25. Improved graft survival after renal transplantation in the United States, 1988 to 1996
26. Donor blood monocytes but not T or B cells facilitate long-term allograft survival after TLI
27. Monocyte-derived dendritic cell precursors facilitate tolerance to heart allografts after TLI
28. Comparison of chimeric and non-chimeric tolerance using posttransplant TLI: Cytokine expression and chronic rejection
29. Total lymphoid irradiation in autoimmune diseases and organ transplantation
30. Hodgkin's disease
31. Kidney allograft survival in dogs treated with total lymphoid irradiation
32. Transplant-lite: Induction of graf-versus-malignancy using fludarabine-based non-ablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
33. Suppression of the mixed leukocyte response and of graft-versus-host disease by spleen cells following total lymphoid irradiation (TLI)
34. + donor T cells fail to induce experimental acute graft-versus-host disease
35. Cyclosporine facilitates chimeric and inhibits nonchimeric tolerance after posttransplant total lymphoid irradiation
36. + T cells in mice conditioned with TLI protects against GVHD
37. + cells: New clues to their origin, specificity, and function
38. Mixed chimerism: Preclinical studies and clinical applications
39. + T cell populations
40. T cell depletion for GVHD prevention in humans
41. Actively acquired tolerance of foreign cells
42. Transplantation tolerance in primates following total lymphoid irradiation (TLI) and bone marrow (BM) injection
43. Total lymphoid irradiation in kidney and liver transplantation in the baboon: Prolonged graft survival and alteration in T cell subsets with low cumulative dose regimens
44. Role of cytokines in determining T-lymphocyte function
45. Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease
46. - alpha beta bone marrow T cells with suppressor activity
47. + T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation
48. Clinical and immunological studies of cadaveric renal transplant recipients given total-lymphoid irradiation and maintained on low-dose prednisone
49. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regiment
50. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: Long-term survival of allogeneic bone marrow and skin grafts
51. Transplantation of allogeneic bone marrow without graft versus host disease using total lymphoid irradiation
52. Transplantation tolerance in adult rats using total lymphoid irradiation: Permanent survival of skin, heart, and marrow allografts
53. Transplantation of bone marrow in outbred dogs without graft versus host disease using total lymphoid irradiation
54. Non-myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
55. Allograft tolerance after total lymphoid irradiation (TLI)
56. Induction of specific unresponsiveness to heart allografts in mongrel dogs treated with total lymphoid irradiation and anti-thymocyte globulin
57. Cloned natural suppressor cells prevent lethal graft-versus-host disease
58. Acquired immune tolerance to cadaveric renal allografts
59. +) T cells which promote tolerance induction and regulate autoimmunity
60. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: Studies of chimerism and anti-donor reactivity
61. Graft-versus-host disease
62. + cells
63. + cell lines
64. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelo-suppressive conditioning
65. The development of a posttransplant TLI treatment strategy that promotes organ allograft acceptance without chronic immunosuppression
66. Total lymphoid irradiation and organ transplantation
67. Influence of overall treatment time in a fractionated total lymphoid irradiation as an immunosuppressive therapy in allogeneic bone marrow transplantation in mice
68. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation
69. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment
70. Induction of tolerance to heart allografts in rats using posttransplant TLI and anti-T cell antibodies
71. Mechanisms of tolerance to rat heart allografts using posttransplant TLI
72. Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: Impact on blood progenitor cell transplantation
73. + T cells reciprocally regulate acute graft versus host disease